Sanger Institute researcher honoured by EMBO
Professor Nicole Soranzo becomes an elected member of the European Molecular Biology Organization
Professor Nicole Soranzo joins 48 fellow scientists from 17 countries in being elected as Members of the European Molecular Biology Organization (EMBO). An additional eight researchers from Argentina, Australia, Japan and the US have become Associate Members of the organisation whose mission is to promote excellence in European molecular life sciences research.
Professor Soranzo plays a pivotal role at the Wellcome Sanger Institute in understanding the role of genetics and molecular pathways in determining cardiovascular health. In particular, Nicole explores the relationship between metabolic pathways and signalling in blood cell development and the impact this has on diseases ranging from heart disease to blood clotting and inflammatory disorders.
“I am delighted to be elected to EMBO. Understanding the molecular basis of health and disease, through the lens of genetics, is central to my scientific approach. To join such a distinguished group of scientists is an honour. Yet the scale of science needed to investigate the underlying genetics of complex disease requires worldwide collaboration and I would like to thank everyone in my team and all my collaborators for their dedication, creativity and support.”
Professor Nicole Soranzo Wellcome Sanger Institute
As an EMBO Member, Professor Soranzo will play an active role in helping to guide the organisation’s activities by serving on committees, evaluating funding applications and mentoring young scientists. The latter role is particularly close to her heart; at the Wellcome Sanger Institute, Nicole chairs the Postdoctoral Research Fellows committee that supports the training, career development and mentoring of the next generation of genomics research leaders.
“Nicole is an inspiring scientist whose research is opening up new fields of scientific exploration into the underlying molecular biology of health and disease. Her dedication to nurturing world-class science through collaboration is laying firm foundations for genomic research for years to come and I am thrilled that she has received this honour.”
Professor Sir Mike Stratton Director of the Sanger Institute
Ever since the very first EMBO Council in 1963, new members are nominated and elected by the existing membership. The new members will be formally welcomed at the Annual Members’ Meeting in Heidelberg between 29 and 31 October 2019.
“EMBO Members are excellent scientists who conduct research at the forefront of all life science disciplines, ranging from computational models or analyses of single molecules and cellular mechanics to the study of higher-order systems in development, cognitive neuroscience and evolution.”
Maria Leptin EMBO Director
EMBO is an organization of more than 1800 leading researchers that promotes excellence in the life sciences in Europe and beyond. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a research environment where scientists can achieve their best work.
EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe.
For more information: www.embo.org
The Sanger is one of the world’s leading genome and biodata institutes. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower science globally. Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease and to understand life on Earth. Find out more at www.sanger.ac.uk or follow @sangerinstitute on Twitter, Facebook, LinkedIn and on our Blog.
Wellcome exists to improve health by helping great ideas to thrive. We support researchers, we take on big health challenges, we campaign for better science, and we help everyone get involved with science and health research. We are a politically and financially independent foundation. https://wellcome.org/
Related blog posts
What is a complex disease?
Many common diseases are influenced by a combination of multiple genes and environmental factors. These diseases are referred to as complex ...
17 Jun 2021
Study identifies trigger for ‘head-to-tail’ axis development in human embryo
Researchers have mapped, in new detail, the genetic changes that a human embryo goes through as it develops.
14 Jun 2021
Computer method to help predict outcomes and tailor treatments for patients with inherited heart diseases
Clinicians and scientists analysed how individual genetic changes affect the heart muscle and created a new computer tool to integrate genomic ...